Why the study?
Congenital myopathies usually present with early onset and slow or non-progressive weakness, but data regarding the disease trajectory in adult patients are lacking.
This study provides long-term disease trajectory data for adult congenital myopathy patients, showing generally mild motor disability but highlighting a subset with severe respiratory failure and the existence of adult-onset forms.
May inform genetic testing in adult myopathy; extends natural history data but leaves open prospective validation.
BACKGROUND: Congenital myopathies (CMyo) are a group of rare inherited muscle disorders classified to date according to myopathological features on muscle biopsy. They usually present with an early onset, with a slow or non-progressive muscle weakness. The phenotypic spectrum is wide, ranging from severe early onset forms to milder and later onset conditions. Data regarding the disease trajectory of CMyo in adult patients are lacking. Here, we describe the clinical, myopathological, and genetic features of a large cohort of adult CMyo patients to facilitate their management in adulthood. METHODS: Global data of a cohort of 142 myopathologically and genetically defined adult patients, 76 women and 66 men, followed at Institute of Myology of the Pitié-Salpêtrière Hospital, were retrospectively analyzed focusing on muscular phenotype, cardiac, and respiratory assessment. RESULTS: RYR1-related CMyo was the most represented entity (N = 65, 45%), followed by DNM2-related CMyo (N = 26, 18%). Eighty-two percent of patients presented with a prenatal, infancy or childhood onset, including delayed motor milestones. An adult onset, defined as > 18 years (median age 43 years), was identified in 15% of patients (N = 18). Fifteen percent of patients were wheelchair-bound. The poorest respiratory outcome was found in SELENON-related CMyo patients. CONCLUSIONS: This observational study provides long-term data on disease progression in CMyo. Adult CMyo patients generally presented mild motor disability at follow-up. Nevertheless, a subset of patients experienced loss of gait and severe respiratory failure. CMyo should be considered in the differential diagnosis of adult-onset myopathies due to the rare but possible late-onset forms.
No takes yet. Share an insight, caveat, or question.
Bisciglia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: